Evidence map›Paper›PMID 35720993›Full record

ArticleFrontiers in chemistry2022

Novel Stilbene-Nitroxyl Hybrid Compounds Display Discrete Modulation of Amyloid Beta Toxicity and Structure.

Silvia Hilt, Ruiwu Liu, Izumi Maezawa, Tatu Rojalin, Hnin H Aung, Madhu Budamagunta, Ryan Slez, Qizhi Gong, Randy P Carney, John C Voss

Open access · goldAbstract read
In one paragraph

Article in Frontiers in chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Silvia HiltDepartment of Biochemistry and Molecular Medicine, University of California, Davis, Davis, CA, United States.
Ruiwu LiuDepartment of Biochemistry and Molecular Medicine, University of California, Davis, Davis, CA, United States.
Izumi MaezawaM.I.N.D. Institute and Department of Pathology and Laboratory Medicine, University of California, Davis, Davis, CA, United States.
Tatu RojalinDepartment of Biomedical Engineering, University of California, Davis, Davis, CA, United States.
Hnin H AungDivision of Cardiovascular Medicine, Department of Internal Medicine, School of Medicine, University of California, Davis, Davis, CA, United States.
Madhu BudamaguntaDepartment of Biochemistry and Molecular Medicine, University of California, Davis, Davis, CA, United States.
Ryan SlezDepartment of Biochemistry and Molecular Medicine, University of California, Davis, Davis, CA, United States.
Qizhi GongDepartment of Cell Biology and Human Anatomy, School of Medicine, University of California, Davis, Davis, CA, United States.
Randy P CarneyDepartment of Biomedical Engineering, University of California, Davis, Davis, CA, United States.
John C VossDepartment of Biochemistry and Molecular Medicine, University of California, Davis, Davis, CA, United States.
University of California, Davis · USCalifornia Air Resources Board · US

Funding

UC Davis Alzheimer's Disease Core CenterP30AG010129 · NIA · UNIVERSITY OF CALIFORNIA DAVIS · PI JOHNSON, DAVID K · 1991 to 2020
$28.3M
NIA NIH HHS P30 AG010129
6 · The paper itself

Abstract

Several neurodegenerative diseases are driven by misfolded proteins that assemble into soluble aggregates. These "toxic oligomers" have been associated with a plethora of cellular dysfunction and dysregulation, however the structural features underlying their toxicity are poorly understood. A major impediment to answering this question relates to the heterogeneous nature of the oligomers, both in terms of structural disorder and oligomer size. This not only complicates elucidating the molecular etiology of these disorders, but also the druggability of these targets as well. We have synthesized a class of bifunctional stilbenes to modulate both the conformational toxicity within amyloid beta oligomers (AβO) and the oxidative stress elicited by AβO. Using a neuronal culture model, we demonstrate this bifunctional approach has the potential to counter the molecular pathogenesis of Alzheimer's disease in a powerful, synergistic manner. Examination of AβO structure by various biophysical tools shows that each stilbene candidate uniquely alters AβO conformation and toxicity, providing insight towards the future development of structural correctors for AβO. Correlations of AβO structural modulation and bioactivity displayed by each provides insights for future testing

Indexed as

Alzheimer’s diseaseamyloid beta peptide (Aβ)circular dichroism (CD)EPR (electron paramagnetic resonance)oxidative stressprotein aggregationprotein misfolding

Identifiers

PMID35720993
PMCPMC9204515
OpenAlexW4281638025

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.